CNC vs PLRX · P/E 8.4, rev $163.07B vs $77.3M cap
Centene Corp (CNC) versus Pliant Therapeutics Inc (PLRX) — a side-by-side from cached financials, not a winner call.
Centene Corp (CNC) is a healthcare plans company listed on US.
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Latest reported PLRX revenue for 2024-12-31 was $0. Net income was -$210.3M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. PLRX currently screens at market cap $77.3M.
CNC currently screens at market cap $28.19B and trailing P/E 8.4. PLRX currently screens at market cap $77.3M.
Not investment advice. Open the CNC and PLRX stock pages for the full models.
Not investment advice.